Uterine fibroids are benign tumors of the uterus that affect 20-40% of premenopausal women.
- Uterine pressure or pain
- Heavy menstrual bleeding
- Pain with intercourse
- Low back pain
- Frequent urination and increased urinary urgency
Women are at increased risk for developing fibroids if they are African-American, over the age of 40, have not had children, are overweight, or have a first-degree relative with fibroids. Diagnosis is usually confirmed by ultrasound or MRI.
Uterine Fibroid Embolization (UFE):
Uterine fibroid embolization is a minimally invasive treatment option for patients with symptomatic uterine fibroids with less risk, less pain, and less recovery time than traditional surgical options.
Fibroids require a blood supply to grow. To treat uterine fibroids, interventional radiologists access the blood vessels supplying the uterine fibroid by a needle stick and without incisions or stitches. Once a catheter is in the proper position, the supplying blood vessels are embolized or blocked by releasing small particles into the uterine blood vessels. Embolizing the blood vessels starve the fibroids of nutrients causing the fibroids to soften and shrink in size. By doing this procedures, over 90% of patient with fibroids will have symptom relief.
The risks of the procedure are minimal but include infection, bleeding, or adverse reactions to the imaging agents used during the treatment. There is a small risk of inducing menopause, especially in women over 45 years of age. Within the first week following the procedure, some women may experience symptoms of post-embolization syndrome, including pelvic pain and cramping, nausea and low-grade fever. These symptoms may resolve themselves and disappear within 2-7 days.
Uterine Fibroid Embolization Treatment Video
© Merit Medical, Used with Permission.